CS
OYST

Credit Suisse’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Credit Suisse’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6
Closed – – 4483
2022
Q2 		$0 Buy
+6
New +$34 ﹤0.01% 4550

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse's OYST Position: Q3 2022 in Review

Credit Suisse sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2022, closing a stake of 6 shares.

Credit Suisse first reported a position in OYST in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

  • Credit Suisse reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 6 Oyster Point Pharma, Inc. Common Stock shares in Q3 2022.
  • Credit Suisse first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's Oyster Point Pharma, Inc. Common Stock position peaked at $0 in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.